The following Medicines In Practice documents have been archived and are no longer available as downloads from this website. If you would like to have access to any of the documents listed please contact nuth.nyrdtc.rxsupp@nhs.net
<< Return to the current list of Medicines In Practice documents
Document | No | Published |
---|---|---|
Management of Opioid-induced constipation (NE&C) | 09 | Oct 16 |
Management of Opioid-induced constipation (GM) | 09 | Oct 16 |
Management of Opioid-induced constipation (YH) | 09 | Oct 16 |
NOACS for treatment and prevention of VTE | 08 | Oct 16 |
Prucalopride and lubiprostone for chronic constipation (NE & C) | 07 | May 16 |
Prucalopride and lubiprostone for chronic constipation (GM) | 07 | May 16 |
Prucalopride and lubiprostone for chronic constipation (YH) | 07 | May 16 |
Self-Monitoring of Blood Glucose in T2DM (NE & C) | 06 | Jan 14 |
Self-Monitoring of Blood Glucose in T2DM (GM) | 06 | Jan 14 |
Self-Monitoring of Blood Glucose in T2DM (YH) | 06 | Jan 14 |
Newer Combination Inhalers for Asthma | 05 | Mar 13 |
New Oral Anticoagulants in Atrial Fibrillation | 04 | Dec 12 |
Cytisine as an aid for smoking cessation | 03 | Sep 12 |
Clostridium difficile Infection New Treatment Options | 02 | Aug 12 |
Statins for the primary prevention of CVD in low-risk individuals | 01 | Aug 12 |